Psychosocial correlates of medication adherence among HIV-positive, cognitively impaired individuals

References

• Andrade, A. S. A., McGruder, H. F., Wu, A. W., Celano, S. A., Skolasky, R. L., Selnes, O. A., … McArthur, J. C. (2005). A programmable prompting device improves adherence to highly active antiretroviral therapy in HIV-infected subjects with memory impairment. Clinical Infectious Diseases, 41, 875–882. doi:10.1086/432877
   PubMed Web of Science ®Google Scholar
• Arnsten, J. H., Demas, P. A., Grant, R. W., Gourevitch, M. N., Farzadegan, H., Howard, A. A., & Schoenbaum, E. E. (2002). Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users. Journal of General Internal Medicine, 17, 377–381. doi:10.1046/j.1525-1497.2002.10644.x
   PubMed Web of Science ®Google Scholar
• Bangsberg, D. R., Hecht, F. M., Charlebois, E. D., Zolopa, A. R., Holodniy, M., Sheiner, L., … Moss, A. (2000). Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population. AIDS, 14, 357–366. doi:10.1097/00002030-200003100-00008
   PubMed Web of Science ®Google Scholar
• Becker, B. W., Thames, A. D., Woo, E., Castellon, S. A., & Hinkin, C. H. (2011). Longitudinal change in cognitive function and medication adherence in HIV-infected adults. AIDS and Behavior, 15, 1888–1894. doi:10.1007/s10461-011-9924-z
   PubMed Web of Science ®Google Scholar
• Burgoyne, R. W. (2005). Exploring direction of causation between social support and clinical outcome for HIV-positive adults in the context of highly active antiretroviral therapy. AIDS Care, 17, 111–124. doi:10.1080/09540120412331305179
   PubMed Web of Science ®Google Scholar
• Carey, C. L., Woods, S. P., Gonzalez, R., Conover, E., Marcotte, T. D., Grant, I., & Heaton, R. K. (2004). Predictive validity of global deficit scores in detecting neuropsychological impairment in HIV infection. Journal of Clinical and Experimental Neuropsychology, 26, 307–319. doi:10.1080/13803390490510031
   PubMed Web of Science ®Google Scholar
• Casado, J. L., Sabido, R., Perez-Elías, M. J., Antela, A., Oliva, J., Dronda, F., … Fortún, J. (1999). Percentage of adherence correlates with the risk of protease inhibitor (PI) treatment failure in HIV-infected patients. Antiviral Therapy, 4(3), 157–161. doi:10.1097/00002030-199811000-00005
   PubMed Web of Science ®Google Scholar
• Chesney, M. A., Ickovics, J. R., Chambers, D. B., Gifford, A. L., Nedig, J., Zwicki, B., & Wu, A. W. (2000). Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: The AACTG adherence instruments. AIDS Care, 12, 255–266. doi:10.1080/09540120050042891
   PubMed Web of Science ®Google Scholar
• Deschamps, A. E., De Graeve, V., Van Wigngaerden, E., De Saar, V., Vandamme, A.-M., Van Vaerenbergh, K., … De Geest, S. (2004). Prevalence and correlates of nonadherence to antiretroviral therapy in a population of HIV patients using Medication Event Monitoring System. AIDS Patient Care and STDs, 18(11), 644–657. doi:10.1089/apc.2004.18.644
   PubMed Web of Science ®Google Scholar
• DiIorio, C., McCarty, F., DePadilla, L., Resnicow, K., McDonnell Holstad, M., Yeager, K., … Lundberg, B. (2009). Adherence to antiretroviral medication regimens: A test of a psychosocial model. AIDS and Behavior, 13, 10–22. doi:10.1007/s10461-007-9318–4
   PubMed Web of Science ®Google Scholar
• DiMatteo, M. R., Hays, R. D., Gritz, E. R., Bastani, R., Crane, L., Elashoff, R., … Marcus, A. (1993). Patient adherence to cancer control regimens: Scale development and initial validation. Psychological Assessment, 5, 102–112. doi:10.1037/1040-3590.5.1.102
   Google Scholar
• Ettenhofer, M. L., Foley, J., Castellon, S. A., & Hinkin, C. H. (2010). Reciprocal prediction of medication adherence and neurocognition in HIV/AIDS. Neurology, 74, 1217–1222. doi:10.1212/WNL.0b013e3181d8c1ca
   PubMed Web of Science ®Google Scholar
• Ezeabogu, I., Copenhaver, M. M., & Potrepka, J. (2012). The influence of neurocognitive impairment on HIV treatment outcomes among drug-involved people living with HIV/AIDS. AIDS Care, 24, 386–393. doi:10.1080/09540121.2011.608794
   PubMed Web of Science ®Google Scholar
• French, T., Tesoriero, J., & Agins, B. (2011). Changes in stress, substance use and medication beliefs are associated with changes in adherence to HIV antiretroviral therapy. AIDS and Behavior, 15, 1416–1428. doi:10.1007/s10461-010-9762-4
   PubMed Web of Science ®Google Scholar
• Gebo, K. A., Keruly, J., & Moore, R. D. (2003). Association of social stress, illicit drug use, and health beliefs with nonadherence to antiretroviral therapy. Journal of General Internal Medicine, 18, 104–111. doi:10.1046/j.1525-1497.2003.10801.x
   PubMed Web of Science ®Google Scholar
• Gifford, A. L., Bormann, J. E., Shively, M. J., Wright, B. C., Richman, D. D., & Bozzette, S. A. (2000). Predictors of self-reported adherence and plasma HIV concentrations in patients on multidrug antiretroviral regimens. Journal of Acquired Immune Deficiency Syndromes, 23, 386–395. doi:10.1097/00042560-200004150-00005
   PubMed Web of Science ®Google Scholar
• Golin, C. E., Earp, J., Tien, H.-C., Stewart, P., Porter, C., & Howie, L. (2006). A 2-arm, randomized, controlled trial of a motivational interviewing-based intervention to improve adherence to antiretroviral therapy (ART) among patients failing or initiating ART. Journal of Acquired Immune Deficiency Syndromes, 42, 42–51. doi:10.1097/01.qai.0000219771.97303.0a
   PubMed Web of Science ®Google Scholar
• Golin, C. E., Lui, H., Hays, R. D., Miller, L. G., Beck, C. K., Ickovics, J. R., … Wenger, N. S. (2002). A prospective study of predictors of adherence to combination antiretroviral medication. Journal of General Internal Medicine, 17, 756–765. doi:10.1046/j.1525-1497.2002.11214.x
   PubMed Web of Science ®Google Scholar
• Gorman, A. A., Foley, J. M., Ettenhofer, M. L., Hinkin, C. H., & van Gorp, W. G. (2009). Functional consequences of HIV-associated neuropsychological impairment. Neuropsychological Review, 19, 186–203. doi:10.1007/s11065-009-9095-0
   PubMed Web of Science ®Google Scholar
• Gruber, V. A., Sorensen, J. L., & Haug, N. A. (2007). Psychosocial predictors of adherence to highly active antiretroviral therapy. Journal of HIV/AIDS & Social Services, 6, 23–37. doi:10.1300/J187v06n01_03
   Google Scholar
• Heaton, R. K., Miller, S. W., Taylor, M. J., & Grant, I. (2004). Revised comprehensive norms for an expanded Halstead-Reitan battery: Demographically adjusted neuropsychological norms for African American and Caucasian adults. Lutz, FL: Psychological Assessment Resources.
   Google Scholar
• Hellström, K., Lindmark, B., Wahlberg, B., & Fugl-Meyer, A. R. (2003). Self-efficacy in relation to impairments and activities of daily living disability in elderly patients with stroke: A prospective investigation. Journal of Rehabilitation Medicine, 35, 202–207. doi:10.1080/16501970310000836
   PubMed Web of Science ®Google Scholar
• Hinkin, C. H., Barclay, T. R., Castellon, S. A., Levine, A. J., Durvasula, R. S., Marion, S. D., … Longshore, D. (2007). Drug use and medication adherence among HIV-1 infected individuals. AIDS and Behavior, 11, 185–194. doi:10.1007/s10461-006-9152-0
   PubMed Web of Science ®Google Scholar
• Hinkin, C. H., Castellon, S. A., Durvasula, R. S., Hardy, D. J., Lam, M. A., Mason, K. I., … Stefaniak, M. (2002). Medication adherence among HIV+adults: Effects of cognitive dysfunction and regimen complexity. Neurology, 59, 1944–1950.
   PubMed Web of Science ®Google Scholar
• Hinkin, C. H., Hardy, D. J., Mason, K. I., Castellon, S. A., Durvasula, R. S., Lam, M. A., & Stefaniak, M. (2004). Medication adherence in HIV-infected adults: Effect of patient age, cognitive status, and substance abuse. AIDS, 18, S19–S25. doi:10.1097/00002030-200401001-00004
   PubMed Web of Science ®Google Scholar
• Leserman, J., Ironson, G., O’Cleirigh, C., Fordiani, J. M., & Balbin, E. (2008). Stressful life events and adherence in HIV. AIDS Patient Care and STDs, 22, 403–411. doi:10.1089/apc.2007.0175
   PubMed Web of Science ®Google Scholar
• Levine, A. J., Hinkin, C. H., Castellon, S. A., Mason, K. I., Lam, M. A., Perkins, A., … Hardy, D. J. (2005). Variations in patterns of highly active antiretroviral therapy (HAART) adherence. AIDS and Behavior, 9, 355–362. doi:10.1007/s10461-005-9009-y
   PubMed Web of Science ®Google Scholar
• Levine, A. J., Hinkin, C. H., Marion, S. D., Keuning, A., Castellon, S. A., Lam, M. A., … Durvasula, R. S. (2006). Adherence to antiviral medications in HIV: Differences in data collected via self-report and electronic monitoring. Health Psychology, 25, 329–335. doi:10.1037/0278-6133.25.3.329
   PubMed Web of Science ®Google Scholar
• Lovejoy, T. I., & Suhr, J. A. (2009). The relationship between neuropsychological functioning and HAART adherence in HIV-positive adults: A systematic review. Journal of Behavioral Medicine, 32, 389–405. doi:10.1007/s10865-009-9212-9
   PubMed Web of Science ®Google Scholar
• Lui, H., Golin, C. E., Miller, L. G., Hays, R. D., Beck, C. K., Sanandagi, S., … Wenger, N. S. (2001). A Comparison study of multiple measures of adherence to HIV protease inhibitors. Annals of Internal Medicine, 134, 968–977. doi:10.7326/0003-4819-134-10-200105150-00011
   PubMed Web of Science ®Google Scholar
• Malta, M., Strathdee, S. A., Magnanini, M. M. F., & Bastos, F. I. (2008). Adherence to antiretroviral therapy for human immunodeficiency virus/acquired immune deficiency syndrome among drug users: A systematic review. Addiction, 103, 122–1257. doi:10.1111/j.1360-0443.2008.02269.x
   Web of Science ®Google Scholar
• Martin, M., Del Cacho, E., Codina, C., Tuset, M., De Lazzari, E., Mallolas, J., … Ribas, J. (2008). Relationship between adherence level, type of the antiretroviral reginmen, and plasma HIV type 1 RNA viral load: A prospective cohort study. AIDS Research and Human Retroviruses, 24, 1263–1268. doi:10.1089/aid.2008.0141
   PubMed Web of Science ®Google Scholar
• Meade, C. S., Conn, N. A., Skalski, L. M., & Safren, S. A. (2011). Neurocognitive impairment and medication adherence in HIV patients with and without cocaine dependence. Journal of Behavioral Medicine, 34, 128–138. doi:10.1007/s10865-010-9293-5
   PubMed Web of Science ®Google Scholar
• Miller, L. G., Golin, C. E., Hays, R. D., Liu, H., Beck, K., Kaplan, A. H., & Wenger, N. S. (2002). Impact of antiretroviral regimen switches on adherence. HIV Clinical Trials, 3, 355–360. doi:10.1310/NNK4-GAGD-5C1Y-K9QT
   PubMedGoogle Scholar
• Mugavero, M. J., Raper, J. L., Reif, S., Whetten, K., Leserman, J., Thielman, N. M., & Wells Pence, B. (2009). Overload: Impact of incident stressful events on antiretroviral medication adherence and virologic failure in a longitudinal, multisite human immunodeficiency virus cohort study. Psychosomatic Medicine, 71, 920–926. doi:10.1097/PSY.0b013e3181bfe8d2
   PubMed Web of Science ®Google Scholar
• Panos, S. E., Del Re, A. C., Thames, A. D., Arentsen, T. J., Patel, S. M., Castellon, S. A., … Hinkin, C. H. (2013). The impact of neurobehavioral features on medication adherence in HIV: Evidence from longitudinal models. AIDS Care, 26, 79–86. doi:10.1080/09540121.2013.802275
   PubMed Web of Science ®Google Scholar
• Paterson, D. L., Swindells, S., Mohr, J., Brester, M., Vergis, E. N., Squler, C., … Singh, N. (2000). Adherence to protease inhibitor therapy and outcomes in patients with HIV infection. Annals of Internal Medicine, 133, 21–30. doi:10.7326/0003-4819-133-1-200007040-00004
   PubMed Web of Science ®Google Scholar
• Pukay-Martin, N. D., Cristiani, S. A., Saveanu, R., & Bornstein, R. A. (2003). The relationship between stressful life events and cognitive function in HIV-infected men. Journal of Neuropsychiatry and Clinical Neurosciences, 15, 435–441. doi:10.1176/appi.neuropsych.15.4.436
   Web of Science ®Google Scholar
• Rajabiun, S., Coleman, S., & Drainoni, M.-L. (2011). Keeping at-risk persons living with HIV/AIDS in care: A qualitative study of staff perspectives. Journal of HIV/AIDS & Social Services, 10, 120–138. doi:10.1080/15381501.2011.572736
   Google Scholar
• Simoni, J. M., Huh, D., Wilson, I., Shen, J., Goggin, K., Reynolds, N. R., … Honghu, L. (2012). Racial/ethnic disparities in ART adherence in the United States: Findings from the MACH14 Study. Journal of Acquired Immune Deficiency Syndromes, 60, 466–472. doi:10.1097/QA1.0b013e31825db0bd
   PubMed Web of Science ®Google Scholar
• Smith, S. R., Rublein, J. C., Marcus, C., Penick Brock, T., & Chesney, M. A. (2003). A medication self-management program to improve adherence to HIV therapy regimens. Patient Education and Counseling, 50, 187–199. doi:10.1016/S0738-3991(02)00127-1
   PubMed Web of Science ®Google Scholar
• Stirrattt, M. J., & Gordon, C. M. (2007). HIV treatment adherence research and intervention. Journal of HIV/AIDS & Social Services, 6, 9–22. doi:10.1300/J187v06n01_02
   Google Scholar
• Thames, A. D., Moizel, J., Panos, S. E., Patel, S. M., Byrd, D. A., Myers, H. F., … Hinkin, C. H. (2012). Differential predictors of medication adherence in HIV: Findings from a sample of African American and Caucasian HIV-positive drug-using adults. AIDS Patient Care and STDs, 26, 621–630. doi:10.1089/apc.2012.0157
   PubMed Web of Science ®Google Scholar
• Thompson, M. A., Mugavero, M. J., Amico, R., Cargill, V. A., Chang, L. W., Gross, R., … Nachega, J. B. (2012). Guidelines for improving entry into and retention in care and antiretroviral adherence for persons with HIV: Evidence-based recommendations from an international association of physicians in AIDS care panel. Annals of Internal Medicine, 156, 817–833. doi:10.7326/0003-4819-156-11-201206050-00419
   PubMed Web of Science ®Google Scholar
• Tucker, J. S., Orlando, M., Burnam, M. A., Sherbourne, C. D., Kung, F.-Y., & Gifford, A. L. (2004). Psychosocial mediators of antiretroviral nonadherence in HIV-positive adults with substance use and mental health problems. Health Psychology, 23, 262–370. doi:10.1037/0278-6133.23.4.363
   Web of Science ®Google Scholar
• Woods, S. P., Dawson, M. S., Weber, E., Gibson, S., Grant, I., & Atkinson, J. H. (2009). Timing is everything: Antiretroviral nonadherence is associated with impairment in time-based prospective memory. Journal of the International Neuropsychological Society, 15, 42–52. doi:10.1017/S1355617708090012
   PubMed Web of Science ®Google Scholar
• Woods, S. P., Moran, L. M., Carey, C. L., Dawson, M. S., Iudicello, J. E., Gibson, S., … Atkinson, J. H. (2008). Prospective memory in HIV infection: Is “remembering to remember” a unique predictor of self-reported medication management? Archives of Clinical Neuropsychology, 23, 257–270. doi:10.1016/j.acn.2007.12.006
   PubMed Web of Science ®Google Scholar